Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA warning letter
Pharma
Sanofi unit in Ireland dinged by FDA on Altuviiio production
After a site visit by FDA inspectors yielded a Form 483 for Genzyme in early 2026, the Sanofi unit is facing further scrutiny from the regulator.
Fraiser Kansteiner
Jul 1, 2026 2:52pm
Jubilant HollisterStier Montreal site gets FDA warning letter
Jun 25, 2026 8:08am
Medline earns FDA warning letter ire for repeat bacteria issues
Jun 4, 2026 7:36am
ImmunityBio responds to FDA warning letter with new protocols
Apr 6, 2026 3:10pm
ImmunityBio hit with FDA warning letter over Anktiva promotions
Mar 24, 2026 1:15pm
Strides recalls children's pain meds due to contamination
Mar 24, 2026 8:52am
